title: Overexpression of RARgamma increases death of SH-SY5Y neuroblastoma cells in response to retinoic acid but not fenretinide.
authors.forename: B B
authors.initials: BB
authors.lastname: Goranov
authors.forename: Q D
authors.initials: QD
authors.lastname: Campbell Hewson
authors.forename: A D J
authors.initials: AD
authors.lastname: Pearson
authors.forename: C P F
authors.initials: CP
authors.lastname: Redfern
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D048430:Cell Shape / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D017313:Fenretinide / Q000494:pharmacology; D006801:Humans; D009447:Neuroblastoma / Q000378:metabolism* / Q000473:pathology; D018168:Receptors, Retinoic Acid / Q000235:genetics / Q000378:metabolism*; D014162:Transfection; D014212:Tretinoin / Q000494:pharmacology*; D000097768:Retinoic Acid Receptor gamma
chemical_list: D000970:Antineoplastic Agents; D017313:Fenretinide; D018168:Receptors, Retinoic Acid; D014212:Tretinoin; D000097768:Retinoic Acid Receptor gamma